Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M807325200 on November 18, 2008

J. Biol. Chem., Vol. 284, Issue 2, 1106-1115, January 9, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
284/2/1106    most recent
M807325200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewerenz, J.
Right arrow Articles by Maher, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewerenz, J.
Right arrow Articles by Maher, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Basal Levels of eIF2{alpha} Phosphorylation Determine Cellular Antioxidant Status by Regulating ATF4 and xCT Expression*Formula

Jan Lewerenz1 and Pamela Maher2

From the Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037

eIF2{alpha} is part of a multimeric complex that regulates cap-dependent translation. Phosphorylation of eIF2{alpha} (phospho-eIF2{alpha}) is induced by various forms of cell stress, resulting in changes to the proteome of the cell with two diametrically opposed consequences, adaptation to stress or initiation of programmed cell death. In contrast to the robust eIF2{alpha} phosphorylation seen in response to acute insults, less is known about the functional role of basal levels of eIF2{alpha} phosphorylation. Here we show that mouse embryonic fibroblasts expressing a nonphosphorylatable eIF2{alpha} have enhanced sensitivity to diverse toxic insults, including amyloid β-(1–42) peptide (Aβ), a key factor in the pathogenesis of Alzheimer disease. This correlates with impaired glutathione metabolism because of down-regulation of the light chain, xCT, of the cystine/glutamate antiporter system X-c. The mechanistic link between the absence of phospho-eIF2{alpha} and xCT expression is nuclear factor ATF4. Consistent with these findings, long term activation of the phospho-eIF2{alpha}/ATF4/xCT signaling module by the specific eIF2{alpha} phosphatase inhibitor, salubrinal, induces resistance against oxidative glutamate toxicity in the hippocampal cell line HT22 and primary cortical neurons. Furthermore, in PC12 cells selected for resistance against Aβ, increased activity of the phospho-eIF2{alpha}/ATF4/xCT module contributes to the resistant phenotype. In wild-type PC12 cells, activation of this module by salubrinal ameliorates the response to Aβ. Furthermore, in human brains, ATF4 and phospho-eIF2{alpha} levels are tightly correlated and up-regulated in Alzheimer disease, most probably representing an adaptive response against disease-related cellular stress rather than a correlate of neurodegeneration.


Received for publication, September 22, 2008 , and in revised form, November 10, 2008.

* This work was supported, in whole or in part, by National Institutes of Health Grant AG025337 (to P. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. S1.

1 Supported by Fellowship LE1846/2-1 from the Deutsche Forschungsgemeinschaft. Present address: Dept. for Neurology, University Medical Center Hamburg-Eppendorf, Martinstrasse 52, 20246 Hamburg, Germany.

2 To whom correspondence should be addressed: Salk Institute for Biological Studies, 10010 North Torrey Pines Rd., La Jolla, CA 92037. Tel.: 858-453-4100, ext. 1932; Fax: 858-535-9062; E-mail: pmaher{at}salk.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement